- Temozolomide Chemotherapy in Patients with Recurrent Malignant Gliomas
-
Yang SH, Kim MK, Lee TK, Lee KS, Jeun SS, Park CK, Kang JK, Kim MC, Hong YK
- KMID: 2157831
- J Korean Med Sci.
- 2006 Aug;21(4):739-744.
- doi: 10.3346/jkms.2006.21.4.739
Numerous studies have demonstrated the clinical activity of temozolomide, a second-generation alkylating agent, against malignant brain tumors, however, its activity has not been reported in an Asian population. This study... -
- CITED
-
- Close
- SHARE
-
- Close
- Cognitive Dysfunction in Drug-induced Parkinsonism Caused by Prokinetics and Antiemetics
-
Ahn HJ, Yoo WK, Park J, Ma HI, Kim YJ
- KMID: 2344160
- J Korean Med Sci.
- 2015 Sep;30(9):1328-1333.
- doi: 10.3346/jkms.2015.30.9.1328
The use of prokinetics/antiemetics is one of the leading causes of drug-induced parkinsonism (DIP) observed in neurology clinics. Cognitive dysfunction in DIP has recently been recognized, but pathologies related with... -
- CITED
-
- Close
- SHARE
-
- Close
- Neurotoxic Manifestations of an Overdose Intrathecal Injection of Gadopentetate Dimeglumine
-
Park KW, Im SB, Kim BT, Hwang SC, Park JS, Shin WH
- KMID: 1778054
- J Korean Med Sci.
- 2010 Mar;25(3):505-508.
- doi: 10.3346/jkms.2010.25.3.505
The intravenous administration of gadopentetate dimeglumine (GD) is relatively safe and rarely causes systemic toxicity in the course of routine imaging studies. However, the general safety of intrathecal GD has... -
- CITED
-
- Close
- SHARE
-
- Close
